Cargando…
Parkinson’s Disease Drug Development Since 1999: A Story of Repurposing and Relative Success
BACKGROUND: A global overview of drug development programs in Parkinson’s disease over the last few decades is lacking, while such programs are challenging given the multifaceted and heterogeneous nature of the disease. OBJECTIVE: To indirectly assess drug development programs in Parkinson’s disease...
Autores principales: | Boucherie, Deirdre M., Duarte, Gonçalo S., Machado, Tiago, Faustino, Patrícia R., Sampaio, Cristina, Rascol, Olivier, Ferreira, Joaquim J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150606/ https://www.ncbi.nlm.nih.gov/pubmed/33459662 http://dx.doi.org/10.3233/JPD-202184 |
Ejemplares similares
-
Espresso Coffee for the Treatment of Somnolence in Parkinson’s Disease: Results of n-of-1 Trials
por: Ferreira, Joaquim J., et al.
Publicado: (2016) -
Challenges and Perspectives in the Management of Late-Stage Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2020) -
Successful stories of drug repurposing for cancer therapy in hepatocellular carcinoma
por: Attia, Yasmeen M., et al.
Publicado: (2020) -
Progress report on technology transfer at CERN since December 1999
Publicado: (2000) -
Patient-centred management of Parkinson's disease
por: Grimes, David, et al.
Publicado: (2020)